Evidence map›Paper›PMID 34369648›Full record

ArticleEMBO reports2021

BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.

Ashari R Kannangara, Daniel M Poole, Colten M McEwan, Joshua C Youngs, Vajira K Weerasekara, Alex M Thornock, Misael T Lazaro, Eranga R Balasooriya, Laura M Oh, Erik J Soderblom and 3 more

Open access · greenAbstract read
In one paragraph

Article in EMBO reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The Human Autophagy Core Complexes.Annual review of biochemistry · 2026
    Review
  6. Article
  7. Building bridges for autophagy.Nature structural & molecular biology · 2025
    Article
  8. Article
  9. Progress on multifunctional transmembrane protein ATG9A.Cell communication and signaling : CCS · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Ashari R KannangaraDepartment of Chemistry and Biochemistry, Fritz B. Burns Cancer Research Laboratory, Brigham Young University, Provo, UT, USA.
Daniel M PooleDepartment of Chemistry and Biochemistry, Fritz B. Burns Cancer Research Laboratory, Brigham Young University, Provo, UT, USA.
Colten M McEwanDepartment of Chemistry and Biochemistry, Fritz B. Burns Cancer Research Laboratory, Brigham Young University, Provo, UT, USA.
Joshua C YoungsDepartment of Chemistry and Biochemistry, Fritz B. Burns Cancer Research Laboratory, Brigham Young University, Provo, UT, USA.
Vajira K WeerasekaraCenter for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-9668-7091
Alex M ThornockDepartment of Chemistry and Biochemistry, Fritz B. Burns Cancer Research Laboratory, Brigham Young University, Provo, UT, USA.ORCID 0000-0003-0511-4376
Misael T LazaroDepartment of Chemistry and Biochemistry, Fritz B. Burns Cancer Research Laboratory, Brigham Young University, Provo, UT, USA.
Eranga R BalasooriyaDepartment of Chemistry and Biochemistry, Fritz B. Burns Cancer Research Laboratory, Brigham Young University, Provo, UT, USA.ORCID 0000-0002-5491-3089
Laura M OhDepartment of Chemistry and Biochemistry, Fritz B. Burns Cancer Research Laboratory, Brigham Young University, Provo, UT, USA.
Erik J SoderblomProteomics and Metabolomics Shared Resource, Duke University School of Medicine, Durham, NC, USA.
Jonathan J LeeDepartment of Chemistry and Biochemistry, Fritz B. Burns Cancer Research Laboratory, Brigham Young University, Provo, UT, USA.ORCID 0000-0002-7940-1290
Daniel L SimmonsDepartment of Chemistry and Biochemistry, Fritz B. Burns Cancer Research Laboratory, Brigham Young University, Provo, UT, USA.
Joshua L AndersenDepartment of Chemistry and Biochemistry, Fritz B. Burns Cancer Research Laboratory, Brigham Young University, Provo, UT, USA.ORCID 0000-0003-2071-744X
Brigham Young University · USDuke University · USHarvard University · US

Funding

The regulation and targeting of cell survival pathways in cancerR15CA202618 · NCI · BRIGHAM YOUNG UNIVERSITY · PI ANDERSEN, JOSHUA LYON · 2016 to 2019
$864k
NCI NIH HHS R15 CA202618
6 · The paper itself

Abstract

ATG9A, the only multi-pass transmembrane protein among core ATG proteins, is an essential regulator of autophagy, yet its regulatory mechanisms and network of interactions are poorly understood. Through quantitative BioID proteomics, we identify a network of ATG9A interactions that includes members of the ULK1 complex and regulators of membrane fusion and vesicle trafficking, including the TRAPP, EARP, GARP, exocyst, AP-1, and AP-4 complexes. These interactions mark pathways of ATG9A trafficking through ER, Golgi, and endosomal systems. In exploring these data, we find that ATG9A interacts with components of the ULK1 complex, particularly ATG13 and ATG101. Using knockout/reconstitution and split-mVenus approaches to capture the ATG13-ATG101 dimer, we find that ATG9A interacts with ATG13-ATG101 independently of ULK1. Deletion of ATG13 or ATG101 causes a shift in ATG9A distribution, resulting in an aberrant accumulation of ATG9A at stalled clusters of p62/SQSTM1 and ubiquitin, which can be rescued by an ULK1 binding-deficient mutant of ATG13. Together, these data reveal ATG9A interactions in vesicle-trafficking and autophagy pathways, including a role for an ULK1-independent ATG13 complex in regulating ATG9A.

Indexed as

AutophagyUbiquitinAutophagy-Related Protein-1 HomologAutophagy-Related ProteinsSequestosome-1 ProteinAutophagy-Related Protein-1 HomologAutophagy-Related ProteinsSequestosome-1 ProteinUbiquitinATG13ATG9AautophagyBioIDp62

Identifiers

PMID34369648
PMCPMC8490997
OpenAlexW3189438964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.